Low-molecular-weight heparin as prophylaxis against thromboembolism after total hip replacement - The never-ending story? [2] (multiple letters)

Acta Orthopaedica Scandinavica

Volumn 72, Issue 2, 2001, Pages 199-204

  Dahl, Ola E ^a   Bergqvist, David ^b   Cohen, Alexander T ^c   Frostick, Simon P ^d   Hull, Russell D ^e  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLEEDING; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; DEEP VEIN THROMBOSIS; DRUG COST; HUMAN; LETTER; LUNG EMBOLISM; META ANALYSIS; MORTALITY; PROPHYLAXIS; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; COST-BENEFIT ANALYSIS; DRUG COSTS; HEALTH CARE COSTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; PHLEBOGRAPHY; SCANDINAVIA; THROMBOEMBOLISM; WARFARIN; WOUND HEALING;

EID: 0035034836     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.1080/000164701317323507     Document Type: Letter

References (0)